Ten-year survival and prognostic factors in multiple myeloma. Japan Myeloma Study Group. 1994

J Tsuchiya, and H Murakami, and T Kanoh, and M Kosaka, and T Sezaki, and C Mikuni, and M Kawato, and T Takagi, and A Togawa, and T Isobe

Among 1119 Japanese patients with symptomatic multiple myeloma diagnosed between 1965 and 1981, 38 (3.4%) survived more than 10 years. Younger age, low tumour mass (absence of severe anaemia, hypercalcaemia, renal failure, and multiple bone lesions), low plasma cell percentage in bone marrow, mature and intermediate myeloma according to Greipp's criteria, and a positive response to subsequent treatment, were related to long-term survival according to univariate analysis. Multivariate logistic regression analysis indicated younger age and low tumour mass as pretreatment characteristics to be related to long-term survival. Prognostic factors proposed applicable to myeloma were also related to 10-year survival.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses

Related Publications

J Tsuchiya, and H Murakami, and T Kanoh, and M Kosaka, and T Sezaki, and C Mikuni, and M Kawato, and T Takagi, and A Togawa, and T Isobe
November 1985, Archives of internal medicine,
J Tsuchiya, and H Murakami, and T Kanoh, and M Kosaka, and T Sezaki, and C Mikuni, and M Kawato, and T Takagi, and A Togawa, and T Isobe
August 1990, Orvosi hetilap,
J Tsuchiya, and H Murakami, and T Kanoh, and M Kosaka, and T Sezaki, and C Mikuni, and M Kawato, and T Takagi, and A Togawa, and T Isobe
July 2007, JPMA. The Journal of the Pakistan Medical Association,
J Tsuchiya, and H Murakami, and T Kanoh, and M Kosaka, and T Sezaki, and C Mikuni, and M Kawato, and T Takagi, and A Togawa, and T Isobe
May 1987, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
J Tsuchiya, and H Murakami, and T Kanoh, and M Kosaka, and T Sezaki, and C Mikuni, and M Kawato, and T Takagi, and A Togawa, and T Isobe
November 1985, Revue du rhumatisme et des maladies osteo-articulaires,
J Tsuchiya, and H Murakami, and T Kanoh, and M Kosaka, and T Sezaki, and C Mikuni, and M Kawato, and T Takagi, and A Togawa, and T Isobe
December 1999, Hematology/oncology clinics of North America,
J Tsuchiya, and H Murakami, and T Kanoh, and M Kosaka, and T Sezaki, and C Mikuni, and M Kawato, and T Takagi, and A Togawa, and T Isobe
October 1975, Cancer,
J Tsuchiya, and H Murakami, and T Kanoh, and M Kosaka, and T Sezaki, and C Mikuni, and M Kawato, and T Takagi, and A Togawa, and T Isobe
October 1989, Haematologica,
J Tsuchiya, and H Murakami, and T Kanoh, and M Kosaka, and T Sezaki, and C Mikuni, and M Kawato, and T Takagi, and A Togawa, and T Isobe
June 1991, Cancer,
J Tsuchiya, and H Murakami, and T Kanoh, and M Kosaka, and T Sezaki, and C Mikuni, and M Kawato, and T Takagi, and A Togawa, and T Isobe
January 1986, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Copied contents to your clipboard!